{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T05:40:05Z","timestamp":1683265205620},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1993,12,1]],"date-time":"1993-12-01T00:00:00Z","timestamp":754704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[1993,12]]},"DOI":"10.1007\/bf02231777","type":"journal-article","created":{"date-parts":[[2005,10,20]],"date-time":"2005-10-20T22:37:36Z","timestamp":1129847856000},"page":"490-493","source":"Crossref","is-referenced-by-count":1,"title":["Soluble CD4 and CD8 molecules in patients with systemic sclerosis"],"prefix":"10.1007","volume":"12","author":[{"given":"Y.","family":"Tokano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Obara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02231777_CR1","first-page":"342","volume":"38","author":"S. Gupta","year":"1979","unstructured":"Gupta, S., Malaviya, A.N., Rajagopalan, P., Good, R.A. Subsets of human T lymphocytes: imbalance of T cell population in patients with progressive systemic sclerosis. Clin Exp Immunol 1979, 38, 342\u2013348.","journal-title":"Clin Exp Immunol"},{"key":"BF02231777_CR2","first-page":"443","volume":"48","author":"E.C. Keystone","year":"1982","unstructured":"Keystone, E.C., Lau, C., Gladman, D.D., Wilkinson, S., Lee, P., Shore, A. Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies. Clin Exp Immunol 1982, 48, 443\u2013448.","journal-title":"Clin Exp Immunol"},{"key":"BF02231777_CR3","first-page":"375","volume":"69","author":"B. Freundlich","year":"1987","unstructured":"Freundlich, B., Jimenez, A. Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy. Clin Exp Immunol 1987, 69, 375\u2013384.","journal-title":"Clin Exp Immunol"},{"key":"BF02231777_CR4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/ard.49.1.40","volume":"49","author":"R. Gustafsson","year":"1990","unstructured":"Gustafsson, R., T\u00f6tterman, T.H., Klareskog, L., H\u00e4llgren, R. Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis. Ann Rheum Dis 1990, 49, 40\u201345.","journal-title":"Ann Rheum Dis"},{"key":"BF02231777_CR5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/art.1780330310","volume":"33","author":"D. Degiannis","year":"1990","unstructured":"Degiannis, D., Seibold, J.R., Czarnecki, M., Raskova, J., Raska, K. Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations. Arthritis Rheum 1990, 33, 375\u2013380.","journal-title":"Arthritis Rheum"},{"key":"BF02231777_CR6","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.4049\/jimmunol.142.7.2230","volume":"142","author":"B.E. Tomkinson","year":"1989","unstructured":"Tomkinson, B.E., Brown, M.C., Ip, S.H., Carrabis, S., Sullivan, J.L. Soluble CD8 during T cell activation. J Immunol 1989, 142, 2230\u20132236.","journal-title":"J Immunol"},{"key":"BF02231777_CR7","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1182\/blood.V72.3.1015.bloodjournal7231015","volume":"72","author":"C. Pui","year":"1988","unstructured":"Pui, C., Ip, S.H., Dodge, R.K., Carrabis, S., Brown, M., Crist, W.M., Berard, C.W., Kung, P., Dahl, G.V., Murphy, S.B. Serum levels of CD8 antigen in childhood lymphoid malignancies: A possible indicator of increased suppressor cell activity in poor-risk patients. Blood 1988, 72, 1015\u20131021.","journal-title":"Blood"},{"key":"BF02231777_CR8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2249.1991.tb05785.x","volume":"86","author":"S. Furukawa","year":"1991","unstructured":"Furukawa, S., Matsubara, T., Tsuji, K., Motohashi, T., Okumura, K., Yabuta, K. Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin Exp Immunol 1991, 86, 134\u2013139.","journal-title":"Clin Exp Immunol"},{"key":"BF02231777_CR9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2249.1991.tb05786.x","volume":"86","author":"K.T. Nouriaria","year":"1991","unstructured":"Nouriaria, K.T., Lombard, M., Williams, R. High serum levels of CD8 antigen in primary biliary cirrhosis: a possible cause of suppressor cell dysfunction? Clin Exp Immunol 1991, 86, 140\u2013144.","journal-title":"Clin Exp Immunol"},{"key":"BF02231777_CR10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2249.1990.tb03292.x","volume":"80","author":"J.A. Symons","year":"1990","unstructured":"Symons, J.A., Wood, N.C., DiGiovine, F.S., Duff, G.W. Soluble CD8 in patients with rheumatic diseases. Clin Exp Immunol 1990, 80, 354\u2013359.","journal-title":"Clin Exp Immunol"},{"key":"BF02231777_CR11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0002-9343(92)90103-I","volume":"92","author":"S. Sawada","year":"1991","unstructured":"Sawada, S., Sugai, S., Iijima, S., Takei, M., Paredes, E., Hayama, T., Nishimura, S., Hosokawa, Y., Horie, T., Obara, T. Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sj\u00f6gren's syndrome. Am J Med 1991, 92, 134\u2013140.","journal-title":"Am J Med"},{"key":"BF02231777_CR12","doi-asserted-by":"crossref","unstructured":"Sawada, S., Iijima, S., Hashimoto, H., Tokano, Y., Takei, M., Shida, M., Horie, T., Obara, T. Increased soluble CD8, CD4 molecule in patients with systemic lupus erythematosus. J Rheumatol 1992, revised.","DOI":"10.1002\/jcla.1860070303"},{"key":"BF02231777_CR13","doi-asserted-by":"crossref","unstructured":"Subcommittee for scleroderma criteria for the American Rheumatism Association, diagnostic and therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23, 581\u2013590.","DOI":"10.1002\/art.1780230510"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02231777.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02231777\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02231777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T05:03:24Z","timestamp":1683263004000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02231777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,12]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,12]]}},"alternative-id":["BF02231777"],"URL":"https:\/\/doi.org\/10.1007\/bf02231777","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,12]]}}}